RNXT (RenovoRx) Dividends Received


RNXT RenovoRx Inc RNXT
33 GF Score
Price $0.93
! 2 Warning Signs
View Full Analysis

What is RenovoRx Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

RNXT
33GF Score
RenovoRx Inc RNXT
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RenovoRx Business Description

Address 2570 West El Camino Real, Suite 320, Mountain View, CA, USA, 94040
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
33GF Score

Get the complete analysis for RNXT

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.93
Price